These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25144358)

  • 1. Postictal agitation syndrome or anxiety symptoms.
    Swartz CM
    J ECT; 2014 Sep; 30(3):e27. PubMed ID: 25144358
    [No Abstract]   [Full Text] [Related]  

  • 2. Postictal agitation after electroconvulsive therapy.
    Tzabazis AZ; Schmitt HJ; Muenster T
    J ECT; 2014 Sep; 30(3):e27-8. PubMed ID: 24820949
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine.
    Cohen MB; Stewart JT
    J ECT; 2013 Jun; 29(2):e23-4. PubMed ID: 23519222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.
    Tzabazis A; Schmitt HJ; Ihmsen H; Schmidtlein M; Zimmermann R; Wielopolski J; Münster T
    J ECT; 2013 Sep; 29(3):189-95. PubMed ID: 23792779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
    Brydges D; Tibrewal P; Waite S; Dhillon R
    Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
    Bryson EO; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
    O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
    J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.
    O'Brien EM; Rosenquist PB; Kimball JN; Dunn GN; Smith B; Arias LM
    J ECT; 2010 Jun; 26(2):131-3. PubMed ID: 19710618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using propofol as salvage therapy to contain severe drug-induced agitation in the Emergency Department: a case report.
    Ting JY; Chatterjee R
    Eur J Emerg Med; 2008 Aug; 15(4):242-3. PubMed ID: 19078826
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence agitation: is there a European consensus?
    Almenrader N; Galante D; Engelhardt T
    Br J Anaesth; 2014 Sep; 113(3):515-6. PubMed ID: 25135891
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of propofol for sedation in the ICU.
    Covington H
    Crit Care Nurse; 1998 Aug; 18(4):34-9. PubMed ID: 9814186
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspiration and postictal agitation after electroconvulsive therapy with propofol but no succinylcholine or atropinic agent.
    Swartz CM
    J ECT; 2005 Mar; 21(1):50-1. PubMed ID: 15791180
    [No Abstract]   [Full Text] [Related]  

  • 15. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of severe postictal agitation after electroconvulsive therapy with bispectrum electroencephalogram index monitoring: a case report.
    Kranaster L; Janke C; Hoyer C; Sartorius A
    J ECT; 2012 Jun; 28(2):e9-10. PubMed ID: 22622306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of propofol in palliative medicine.
    Moyle J
    J Pain Symptom Manage; 1995 Nov; 10(8):643-6. PubMed ID: 8594126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol for palliative sedation.
    Sulistio M; Wojnar R; Michael NG
    BMJ Support Palliat Care; 2020 Mar; 10(1):4-6. PubMed ID: 31488420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.
    Devanand DP; Sackeim HA
    Gen Hosp Psychiatry; 1992 Sep; 14(5):345-9. PubMed ID: 1521790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose propofol drip for palliative sedation: a case report.
    Herndon CM; Zimmerman E
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):492-5. PubMed ID: 18550779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.